Oxazolidinone bacteriophage containing azaheterocycle

A technology of isoxazolidoxy and alkyl groups, applied in the field of medicine, can solve the problems of severe, single variety of oxazolidinone antibiotics, and continuous emergence of linezolid resistance.

CN102190656AActive Publication Date: 2011-09-21BEIJING AOHE DRUG RES INST
3 Cites 7 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2011-09-21

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention belongs to the technical field of medicaments and in particular relates to oxazolidinone bacteriophage containing azaheterocycle, pharmaceutically-acceptable salts or stereoisomeride thereof, wherein the oxazolidinone bacteriophage is shown as a general formula (I) in the specification, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X, Y and Z are defined as a description. The invention also relates to a preparation method of the compound, a medicinal composition containing the compound as well as application of the compound or the medicinal compound thereof to preparation of medicines for treating and / or preventing infectious diseases.
Need to check novelty before this filing date? Find Prior Art

Description

1. Technical field

[0001] The invention belongs to the technical field of medicine, and in particular relates to an oxazolidinone antibiotic containing a five-membered heterocycle, a pharmaceutically acceptable salt thereof or a stereoisomer thereof, a preparation method thereof, and a pharmaceutical composition containing the compound , and the application of the compound or its pharmaceutical composition in the preparation of medicines for treating and / or preventing infectious diseases. 2. Background technology

[0002] Oxazolidinone antibacterial drugs are a new type of chemically synthesized antibacterial drugs developed after sulfonamides and fluoroquinolones, which can inhibit multi-drug resistant Gram-positive bacteria.

[0003] Linezolid is the first marketed oxazolidinone antibiotic.

[0004]

[0005] It has a strong inhibitory effect on Gram-positive bacteria and has no cross-resistance with other antibacterial drugs. Its unique mechanism of action inhibits th...

Examples

Embodiment 1

[0121] Example 1 (S)-N-[[3-[4-[5-[[(1H-1,2,3-triazol-5-yl)methylamino]methyl]thiophen-2-yl] -3-Fluorophenyl]-2- Preparation of Carbonyloxazolidin-5-yl]methyl]acetamide Hydrochloride (Compound 1 Hydrochloride)

[0122]

[0123] (1) Preparation of N-[(5-bromothiophen-2-yl)methyl]propyn-2-yl-1-amine

[0124]

[0125] In a dry reaction flask, add propargylamine 9.5g (172mmol), 5-bromothiophene-2-carbaldehyde 30g (158mmol) and 1,2-dichloroethane 450mL, stir at room temperature for 2h, then add triethoxy 43.3 g (203 mmol) of sodium borohydride was stirred overnight at room temperature, the reaction solution was washed with water, and the organic phase was directly used in the next step without further treatment.

[0126] (2) Preparation of tert-butyl (5-bromothiophen-2-yl) methyl (propyn-2-yl) carbamate

[0127]

[0128] Add 14.5 g (143 mmol) of triethylamine to the organic solution obtained in the previous step, cool to 0°C, and dropwise add (Boc) 2 O acid anhydride ...

Embodiment 2

[0146] Example 2 (5R)-3-[4-[5-[[(1H-1,2,3-triazol-5-yl)methylamino]methyl]thiophen-2-yl]-3- Fluorobenzene Preparation of -5-(hydroxymethyl)oxazolidin-2-one (compound 4)

[0147]

[0148] (1) tert-butyl[5-[2-fluoro-4-[(R)-5-(hydroxymethyl)-2-oxo-3-oxazolidinyl]phenyl]thiophen-2-yl] Preparation of carbamate

[0149]

[0150] (R)-3-[3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-5-( Hydroxymethyl) oxazolidin-2-one 8g (23.7mmol), tert-butyl (5-bromothien-2-yl) carbamate 6.9g (23.7mmol), sodium carbonate 5g (47.5mmol), Pd (dppf)Cl 2 Dissolve 0.8g in dioxane, heat to 90°C under the protection of nitrogen and react overnight, cool the reaction solution to room temperature, add water and extract with ethyl acetate, wash the organic layer three times with saline, combine the organic layers, concentrate and pass through the column layer Analysis and separation (DCM:MeOH=20:1) gave 6g of the product.

[0151] (2) Preparation of (R)-3-[4-[5-(aminomethyl)th...

Embodiment 3

[0162] Example 3 (5R)-5-[(1H-1,2,3-triazol-1-yl)methyl]-3-[4-[5-[[(1H-1,2,3- Triazol-5-yl)methylamino] Preparation of methyl]thiophen-2-yl]-3-fluorophenyl]oxazolidin-2-one (compound 5)

[0163]

[0164] (1) (R)-[3-(4-bromo-3-fluorobenzene)-2-carbonyl-oxazolidin-5-yl]methyl 4-methylbenzenesulfonate

[0165]

[0166] Dissolve (R)-3-(4-bromo-3-fluorobenzene)-5-(hydroxymethyl)oxazolidin-2-one (20 g, 69.2 mol) in DCM, add triethylamine (21 g, 207.6mmol) and TosCl (15.8g, 83.1mmol), the reaction solution was stirred overnight at room temperature. The reaction solution was washed with saturated sodium bicarbonate, the organic layer was concentrated to obtain a solid, washed three times with dichloromethane, filtered and dried to obtain a white solid (R)-[3-(4-bromo-3-fluorobenzene)-2-carbonyl-oxane oxazolidin-5-yl]methyl 4-methylbenzenesulfonate 24g.

[0167] (2) (R)-5-(azidomethyl)-3-(4-bromo-3-fluorophenyl)oxazolidin-2-one

[0168]

[0169] (R)-[3-(4-Bromo-3-fluoro...